Syra Health Q2 FY26 swings to profit of $250,242; revenue rises 23% to $2.4 million

Syra Health swung to a GAAP profit in Q2 2026, posting net income of $250,242 versus a loss a year earlier; EPS was $0.02.

Revenue rose 23% year over year to $2.4 million; gross margin widened 5.8 percentage points to 44.5%.

GAAP operating income was $251,571; GAAP EBITDA turned positive to $253,200 from a loss a year earlier.

Population health solutions revenue increased 8% to $1.72 million; healthcare workforce revenue more than doubled to $678,113.

Syra Health reiterated its 2026 target for full-year profitability, citing contract extensions and expected near-term CMS ACCESS Model approval with HealthSync.